Centrus Energy sells low-enriched uranium (LEU) to current reactors and plans to produce high-assay low-enriched uranium (HALEU) for next-gen reactors. Profitable with a strong cash position, it depends on foreign sources for LEU supply. Stock up 295% in 2025. Has first American-owned HALEU plant. Potential for growth with HALEU production.

Centrus offers LEU for current reactors and DOE services for HALEU for advanced reactors. Holds sole NRC license in the U.S. for HALEU production. Despite Russian supply contract, Centrus aims for self-sufficiency. Profitable, with strong gross profit and cash balance. Faces volatility and supply constraints.

Policy support and international interest boost Centrus, but limited production capacity hinders scaling. Stock trades at high valuation, reflecting growth expectations. Investors eye Centrus’ ability to scale enrichment capacity for returns. Stock Advisor doesn’t include Centrus in top 10 stocks. Consider risks before investing in Centrus Energy.

Read more at Yahoo Finance: Up Over 450% in the Past Year, Is This Stock a No-Brainer Buy Now?